Delivery Order SPE2DB22D1103-SPE2DB24FTQJ0
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,957.44 firm-fixed-price award is for the delivery of Humalog 100 unit/mL KwikPen 3mL, a diabetes medication. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,024.32, is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a medical product. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
- This federal contract award, valued at $1,024.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a medical product. This is a firm fixed-price delivery order contract with a completion date of May 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,166.70, is a delivery order for the supply of Humalog 100 Unit/mL Kwikpen 3mL, a diabetes medication. The contract has an ultimate completion date of August 30, 2024, and a firm fixed price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humalog 100 Unit/mL KwikPen 3mL, a diabetes medication. The contract has a ceiling value of $1,059.72 and a period of performance ending on April 18, 2025. The contract is a firm fixed-price delivery order, which indicates it was competed without any set-aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,357.41, is for the procurement of Humalog 100 Unit/mL Kwikpen 3mL, a medical supply used for the treatment of diabetes. The contract has an ultimate completion date of December 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.65 firm fixed price contract is for the supply of Humalog 100 unit/mL Kwikpen, a diabetes medication. The contract has a completion date of July 14, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award is a delivery order valued at $4,202.81 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a pharmaceutical product. The award has an ultimate completion date of January 17, 2025 and utilizes a firm fixed price pricing type. The contract is not designated with a set-aside. AmerisourceBergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,227.11 contract is for the supply of Humalog 100 Unit/mL KwikPen 3mL, a diabetes medication. The contract has a period of performance through June 4, 2024 and is a firm fixed-price agreement. No set-aside designation was used. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,115.40, is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a period of performance through May 2, 2024. No set-aside designation was indicated for this award. AmerisourceBergen maintains a significant Indefinite...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTQJ0Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humalog 100 Unit/mL KwikPen 3mL. The contract has a firm fixed price of $1,459.74 and an ultimate completion date of August 20, 2024. This award is not a set-aside contract. As a leading supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with agencies such as the DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000, to provide a wide range of critical medical commodities to support military treatment programs, veterans' healthcare, and other federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/19/24 |